CervoMed Inc.

NASDAQ: CRVO
Share price (12/23/24): $2.21
Market cap (12/23/24): $18.2 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 09/30/24 Q3

ended 06/30/24 Q2

ended 03/31/24 Q1

ended 12/31/23 FY 2023

ended 09/30/23 Q3

Prospectuses and Registrations Filter

Prospectus supplement

Prospectus supplement

Shelf registration

Updated info for already-effective prospectus

Prospectus supplement

Ownership Filter

AWM Investment Company, Inc.

Elder William Robert

Gregoire Sylvie

News Filter

Announces Topline Data From RewinD-LB Phase 2b Clinical Trial in Patients With Dementia With Lewy Bodies

Material Disclosure, Financial Statements or Exhibits

Announces Orphan Drug Designation Granted to Neflamapimod by U.S. Food and Drug Administration for the Treatment of Frontotemporal Dementia

Reports Third Quarter 2024 Financial Results and Provides Corporate Updates

Announces Key Takeaways From Oral Presentations at the 17th Clinical Trials on Alzheimer's Disease Conference

Proxies Filter

Definitive proxy

Additional info about upcoming vote

Additional info about upcoming vote

Revised preliminary proxy by non-management

Proxy in contested situation

Other Filter

Notice of effectiveness

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Notice of effectiveness